These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11786405)

  • 1. Anti-CD3/anti-epidermal growth factor receptor-bispecific antibody retargeting of lymphocytes against human neoplastic keratinocytes in an autologous organotypic culture model.
    Renard I; Mezzanzanica D; Canevari S; Ferrini S; Boniver J; Delvenne P; Jacobs N
    Am J Pathol; 2002 Jan; 160(1):113-22. PubMed ID: 11786405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organotypic culture of HPV-transformed keratinocytes: a model for testing lymphocyte infiltration of (pre)neoplastic lesions of the uterine cervix.
    Jacobs N; Moutschen MP; Franzen-Detrooz E; Boniver V; Boniver J; Delvenne P
    Virchows Arch; 1998 Apr; 432(4):323-30. PubMed ID: 9565341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of T lymphocytes against EGF-receptor+ tumor cells by bispecific monoclonal antibodies: requirement of CD3 molecule cross-linking for T-cell activation.
    Ferrini S; Cambiaggi A; Sforzini S; Marciano S; Canevari S; Mezzanzanica D; Colnaghi MI; Grossi CE; Moretta L
    Int J Cancer; 1993 Dec; 55(6):931-7. PubMed ID: 8253530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of tumour cell lysis by a bispecific antibody recognising epidermal growth factor receptor (EGFR) and CD3.
    Knuth A; Bernhard H; Jäger E; Wölfel T; Karbach J; Jäggle C; Strittmatter W; Meyer zum Büschenfelde KH
    Eur J Cancer; 1994; 30A(8):1103-7. PubMed ID: 7654439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo stability and anti-tumour efficacy of an anti-EGFR/anti-CD3 F(ab')2 bispecific monoclonal antibody.
    Negri DR; Tosi E; Valota O; Ferrini S; Cambiaggi A; Sforzini S; Silvani A; Ruffini PA; Colnaghi MI; Canevari S
    Br J Cancer; 1995 Oct; 72(4):928-33. PubMed ID: 7547242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colonization of in vitro-formed cervical human papillomavirus- associated (pre)neoplastic lesions with dendritic cells: role of granulocyte/macrophage colony-stimulating factor.
    Hubert P; van den Brüle F; Giannini SL; Franzen-Detrooz E; Boniver J; Delvenne P
    Am J Pathol; 1999 Mar; 154(3):775-84. PubMed ID: 10079255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defensins induce the recruitment of dendritic cells in cervical human papillomavirus-associated (pre)neoplastic lesions formed in vitro and transplanted in vivo.
    Hubert P; Herman L; Maillard C; Caberg JH; Nikkels A; Pierard G; Foidart JM; Noel A; Boniver J; Delvenne P
    FASEB J; 2007 Sep; 21(11):2765-75. PubMed ID: 17470569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of growth of normal and human papillomavirus-transformed keratinocytes in monolayer and organotypic cultures by interferon-gamma and tumor necrosis factor-alpha.
    Delvenne P; al-Saleh W; Gilles C; Thiry A; Boniver J
    Am J Pathol; 1995 Mar; 146(3):589-98. PubMed ID: 7887441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD30-antigen-specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: potential use for the treatment of Hodgkin's lymphoma.
    Pohl C; Denfeld R; Renner C; Jung W; Bohlen H; Sahin U; Hombach A; van Lier R; Schwonzen M; Diehl V
    Int J Cancer; 1993 Jul; 54(5):820-7. PubMed ID: 7686889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem Cell Properties of Normal Human Keratinocytes Determine Transformation Responses to Human Papillomavirus 16 DNA.
    Woappi Y; Hosseinipour M; Creek KE; Pirisi L
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29593030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of human papillomavirus-specific CD4(+) and CD8(+) lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- and 18-positive cervical cancer.
    Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Zhan D; Pecorelli S; Parham GP; Cannon MJ
    J Virol; 1999 Jul; 73(7):5402-10. PubMed ID: 10364287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of anti-CD3 and anti-CD16 bispecific monoclonal antibodies for the targeting of T and NK cells against tumor cells.
    Ferrini S; Cambiaggi A; Sforzini S; Canevari S; Mezzanzanica D; Colnaghi MI; Moretta L
    Cancer Detect Prev; 1993; 17(2):295-300. PubMed ID: 8402715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The organotypic culture of HPV-transformed keratinocytes: an effective in vitro model for the development of new immunotherapeutic approaches for mucosal (pre)neoplastic lesions.
    Delvenne P; Hubert P; Jacobs N; Giannini SL; Havard L; Renard I; Saboulard D; Boniver J
    Vaccine; 2001 Mar; 19(17-19):2557-64. PubMed ID: 11257392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells induce the death of human papillomavirus-transformed keratinocytes.
    Hubert P; Giannini SL; Vanderplasschen A; Franzen-Detrooz E; Jacobs N; Boniver J; Delvenne P
    FASEB J; 2001 Nov; 15(13):2521-3. PubMed ID: 11641258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma.
    Gedeon PC; Schaller TH; Chitneni SK; Choi BD; Kuan CT; Suryadevara CM; Snyder DJ; Schmittling RJ; Szafranski SE; Cui X; Healy PN; Herndon JE; McLendon RE; Keir ST; Archer GE; Reap EA; Sanchez-Perez L; Bigner DD; Sampson JH
    Clin Cancer Res; 2018 Aug; 24(15):3611-3631. PubMed ID: 29703821
    [No Abstract]   [Full Text] [Related]  

  • 16. Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE), is highly active against primary uterine serous papillary carcinoma cell lines in vitro.
    Bellone S; Black J; English DP; Schwab CL; Lopez S; Cocco E; Bonazzoli E; Predolini F; Ferrari F; Ratner E; Silasi DA; Azodi M; Schwartz PE; Santin AD
    Am J Obstet Gynecol; 2016 Jan; 214(1):99.e1-8. PubMed ID: 26272866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further characterization of cytotoxic T cells generated by short-term culture of human peripheral blood lymphocytes with interleukin-2 and anti-CD3 mAb.
    Jacobs N; Greimers R; Mazzoni A; Trebak M; Schaaf-Lafontaine N; Boniver J; Moutschen MP
    Cancer Immunol Immunother; 1996 Jul; 42(6):369-75. PubMed ID: 8830741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bispecific monoclonal antibody anti-CD3 x anti-tenascin: an immunotherapeutic agent for human glioma.
    Davico Bonino L; De Monte LB; Spagnoli GC; Vola R; Mariani M; Barone D; Moro AM; Riva P; Nicotra MR; Natali PG
    Int J Cancer; 1995 May; 61(4):509-15. PubMed ID: 7538978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bispecific light T-cell engagers for gene-based immunotherapy of epidermal growth factor receptor (EGFR)-positive malignancies.
    Mølgaard K; Harwood SL; Compte M; Merino N; Bonet J; Alvarez-Cienfuegos A; Mikkelsen K; Nuñez-Prado N; Alvarez-Mendez A; Sanz L; Blanco FJ; Alvarez-Vallina L
    Cancer Immunol Immunother; 2018 Aug; 67(8):1251-1260. PubMed ID: 29869168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of natural killer-like T immunologic effector cells against leukemia and lymphoma cells by reverse antibody-dependent cellular cytotoxicity.
    Lefterova P; Märten A; Buttgereit P; Weineck S; Scheffold C; Huhn D; Schmidt-Wolf IG
    J Immunother; 2000; 23(3):304-10. PubMed ID: 10838659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.